Search results
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to...
The Longview News-Journal· 3 days ago- Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
AbbVie CEO latest heavy hitter to buy in Boca Raton
The Real Deal via Yahoo Finance· 4 hours agoAbbVie's Richard Gonzalez with 650 Tern Point Circle in Boca Raton (Daniel Petroni, AbbVie)AbbVie CEO Richard Gonzalez is the latest ...
AbbVie Inc. (NYSE:ABBV) to Post Q2 2024 Earnings of $3.01 Per Share, Zacks Research Forecasts
ETF DAILY NEWS· 21 hours agoAbbVie Inc. (NYSE:ABBV – Free Report) – Analysts at Zacks Research lifted their Q2 2024 earnings estimates for shares of AbbVie in a research report issued ...
Earnings call: AbbVie projects robust growth and diversified pipeline
Investing.com· 2 days agoWith a growth platform that accounts for 80% of AbbVie's business, the company saw mid-teens growth...
Abbvie Inc (NYSE: ABBV) Jumps 1.36%: What Could Be On The Way Going Forward? – Stocks Register
Stocks Register· 17 hours agoAbbvie Inc (NYSE:ABBV) shares, rose in value on Wednesday, May 15, with the stock price up by 1.36% to the previous day’s close as strong demand from buyers drove the stock ...
Kristin Chenoweth defends Ariana Grande over rumors that she was dating her 'Wicked' costar
INSIDER via Yahoo News· 10 hours ago"Wicked' actor Ethan Slater.Bruce Glikas/Getty Images Chenoweth — who sat down with Business Insider...
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Zacks via Yahoo Finance· 2 days agoAbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
ABBV Stock Sees Surge of Approximately 2.08% in Last Five Days – Knox Daily
Knox Daily· 17 hours agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Abbvie Inc shares valued at $3,716,757 were sold by Donoghoe Nicholas ...
AbbVie shares hold Buy rating with $180 target from TD Cowen By Investing.com
Investing.com· 2 days agoOn Tuesday, TD (TSX:TD) Cowen maintained a positive stance on AbbVie Inc . TD Cowen adjusted its...
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
Zacks· 3 days agoFree Report) announced that it has signed a collaboration and option-to-license agreement with New York-based privately held biotech Gilgamesh Pharmaceuticals to research and develop next-generation ...